MiR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS

Nature Cell Biology

Volumn 19, Issue 10, 2017, Pages 1286-1296

  Wu, Min Zu ^a,b   Cheng, Wei Chung ^c   Chen, Su Feng ^c,d   Nieh, Shin ^d   O'Connor, Carolyn ^a   Liu, Chia Lin ^e   Tsai, Wen Wei ^f   Wu, Cheng Jang ^g   Martin, Lorena ^a,b,h   Lin, Yaoh Shiang ^d,i   Wu, Kou Juey ^c   Lu, Li Fan ^g,j,k   Izpisua Belmonte, Juan Carlos ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b CATHOLIC UNIVERSITY OF MURCIA   (Spain)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^j UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP AMP SYNTHASE; MICRORNA; MICRORNA 25; MICRORNA 93; MITOCHONDRIAL DNA; STEROID RECEPTOR COACTIVATOR 3; SYNTHETASE; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; DNA BINDING PROTEIN; MB21D1 PROTEIN, HUMAN; MB21D1 PROTEIN, MOUSE; MIRN25 MICRORNA, HUMAN; MIRN25 MICRORNA, MOUSE; MIRN93 MICRORNA, HUMAN; MIRN93 MICRORNA, MOUSE; MIXED FUNCTION OXIDASE; NCOA3 PROTEIN, HUMAN; NCOA3 PROTEIN, MOUSE; NUCLEOTIDYLTRANSFERASE; ONCOPROTEIN; TET1 PROTEIN, HUMAN; TET1 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CELL HYPOXIA; CONTROLLED STUDY; DOWN REGULATION; ENZYME REPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; TUMOR HYPOXIA; TUMOR IMMUNITY; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT; ANIMAL; BREAST TUMOR; C57BL MOUSE; DEFICIENCY; DISEASE COURSE; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR ESCAPE;

ADAPTIVE IMMUNITY; ANIMALS; BREAST NEOPLASMS; DISEASE PROGRESSION; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MIXED FUNCTION OXYGENASES; NUCLEAR RECEPTOR COACTIVATOR 3; NUCLEOTIDYLTRANSFERASES; PROTO-ONCOGENE PROTEINS; RECEPTOR, INTERFERON ALPHA-BETA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR ESCAPE; TUMOR HYPOXIA; TUMOR MICROENVIRONMENT;

EID: 85031896067     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3615     Document Type: Article

References (46)

1. Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570 (2011)
2. Zitvogel, L., Tesniere, A. & Kroemer, G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6, 715-727 (2006)
3. Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252 (2009)
4. Palazon, A., Aragones, J., Morales-Kastresana, A., de Landazuri, M. O. & Melero, I. Molecular pathways: hypoxia response in immune cells fighting or promoting cancer. Clin. Cancer Res. 18, 1207-1213 (2012)
5. Noman, M. Z. et al. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response. Crit. Rev. Immunol. 31, 357-377 (2011)
6. Lewis, C. & Murdoch, C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol. 167, 627-635 (2005)
7. Corzo, C. A. et al. HIF-1 regulates function and differentiation of myeloidderived suppressor cells in the tumor microenvironment. J. Exp. Med. 207, 2439-2453 (2010)
8. Noman, M. Z. et al. Tumor-promoting effects of myeloid-derived suppressor cells are potentiated by hypoxia-induced expression of miR-210. Cancer Res. 75, 3771-3787 (2015)
9. Facciabene, A. et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature 475, 226-230 (2011)
10. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009)
11. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A. & Baltimore, D. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10, 111-122 (2010)
12. Esquela-Kerscher, A. & Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269 (2006)
13. Shen, J. et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497, 383-387 (2013)
14. Kulshreshtha, R., Davuluri, R. V., Calin, G. A. & Ivan, M. A microRNA component of the hypoxic response. Cell Death Differ. 15, 667-671 (2008)
15. Noman, M. Z. et al. The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTLmediated cell lysis. J. Immunol. 182, 3510-3521 (2009)
16. Vesely, M. D., Kershaw, M. H., Schreiber, R. D. & Smyth, M. J. Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235-271 (2011)
17. Yang, M. H. et al. Direct regulation of TWIST by HIF-1 promotes metastasis. Nat. Cell Biol. 10, 295-305 (2008)
18. Clambey, E. T. et al. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl Acad. Sci. USA 109, E2784-E2793 (2012)
19. Wu, M. Z. et al. Hypoxia drives breast tumor malignancy through a TET-TNF-p38-MAPK signaling axis. Cancer Res. 75, 3912-3924 (2015)
20. Petrocca, F., Vecchione, A. & Croce, C. M. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 68, 8191-8194 (2008)
21. van den Beucken, T. et al. Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat. Commun. 5, 5203 (2014)
22. Mariani, C. J. et al. TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma. Cell Rep. 7, 1343-1352 (2014)
23. Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903-906 (2013)
24. Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013)
25. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002)
26. Liu, Y. et al. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. J. Hepatol. 63, 114-121 (2015)
27. Rongvaux, A. et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159, 1563-1577 (2014)
28. White, M. J. et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549-1562 (2014)
29. Liu, L. et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxiainduced mitophagy in mammalian cells. Nat. Cell Biol. 14, 177-185 (2012)
30. Kim, H. et al. Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol. Cell 44, 532-544 (2011)
31. Deng, L. et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41, 843-852 (2014)
32. Yan, J. et al. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res. 66, 11039-11046 (2006)
33. Chen, H. et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580 (1997)
34. Percharde, M. et al. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev. 26, 2286-2298 (2012)
35. Kulshreshtha, R. et al. A microRNA signature of hypoxia. Mol. Cell. Biol. 27, 1859-1867 (2007)
36. Hazarika, S. et al. MicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathway. Circulation 127, 1818-1828 (2013)
37. Hu, J. et al. MiR-215 is induced post-transcriptionally via HIF-Drosha complex and mediates glioma-initiating cell adaptation to hypoxia by targeting KDM1B. Cancer Cell 29, 49-60 (2016)
38. Haldar, S., Roy, A. & Banerjee, S. Differential regulation of MCM7 and its intronic miRNA cluster miR-106b-25 during megakaryopoiesis induced polyploidy. RNA Biol. 11, 1137-1147 (2014)
39. Ramalingam, P. et al. Biogenesis of intronic miRNAs located in clusters by independent transcription and alternative splicing. RNA 20, 76-87 (2014)
40. Camps, C. et al. Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia. Mol. Cancer 13, 28 (2014)
41. Petrocca, F. et al. E2F1-regulated microRNAs impair TGF-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13, 272-286 (2008)
42. Corrales, L. & Gajewski, T. F. Molecular pathways: targeting the stimulator of interferon genes (STING) in the immunotherapy of cancer. Clin. Cancer Res. 21, 4774-4779 (2015)
43. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994)
44. Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107 (2010)
45. Wu, M. Z. et al. Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. Mol. Cell 43, 811-822 (2011)
46. Lu, L. F. et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142, 914-929 (2010).